Stock Scorer

Anixa Biosciences Inc (ANIX) · Insider trading

What Anixa Biosciences's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$460,322
4 insiders, 18 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
+$460,322
bought less sold
Latest filing
2026-09-30
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01: $186,041 bought 2025-01 2025-06: $28,500 bought 2025-07: $110,700 bought 2025-07 2026-01: $30,400 bought 2026-01 2026-06: $59,987 bought 2026-07: $139,798 bought 2026-07 2026-09: $230,137 bought
Bought Sold Largest month: $230,137

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Kumar AmitDirector, Chief Executive Officer $338,934 – 14 2026-09-24 672,000
Titterton Lewis H jrDirector $335,788 – 12 2026-09-23 1,046,003
Baskies Arnold MDirector $75,250 – 4 2026-09-24 140,572
Catelani MichaelPresident, COO, & CFO $35,591 – 2 2026-09-30 50,000

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-09-30 Catelani MichaelPresident, COO, & CFO Buy 5,500 2.84 $15,620 50,000 Form 4
2026-09-24 Baskies Arnold MDirector Buy 5,000 2.76 $13,800 140,572 Form 4
2026-09-24 Kumar AmitDirector, Chief Executive Officer Buy 7,000 2.78 $19,460 672,000 Form 4
2026-09-23 Titterton Lewis H jrDirector Buy 49,036 2.69 $131,907 1,046,003 Form 4
2026-09-10 Titterton Lewis H jrDirector Buy 10,000 2.73 $27,300 996,967 Form 4
2026-09-10 Kumar AmitDirector, Chief Executive Officer Buy 3,000 2.75 $8,250 665,000 Form 4
2026-09-10 Kumar AmitDirector, Chief Executive Officer Buy 5,000 2.76 $13,800 662,000 Form 4
2026-07-31 Kumar AmitDirector, Chief Executive Officer Buy 5,000 3.47 $17,350 657,000 Form 4
2026-07-27 Kumar AmitDirector, Chief Executive Officer Buy 5,000 3.44 $17,200 652,000 Form 4
2026-07-27 Kumar AmitDirector, Chief Executive Officer Buy 3,188 3.37 $10,744 647,000 Form 4
2026-07-24 Kumar AmitDirector, Chief Executive Officer Buy 3,000 3.73 $11,190 643,812 Form 4
2026-07-20 Kumar AmitDirector, Chief Executive Officer Buy 5,000 3.46 $17,300 640,812 Form 4
2026-07-20 Titterton Lewis H jrDirector Buy 12,000 3.47 $41,640 986,967 Form 4
2026-07-15 Titterton Lewis H jrDirector Buy 2,797 3.28 $9,174 974,967 Form 4
2026-07-10 Kumar AmitDirector, Chief Executive Officer Buy 5,000 3.04 $15,200 635,812 Form 4
2026-06-16 Titterton Lewis H jrDirector Buy 2,836 2.64 $7,487 972,170 Form 4
2026-06-12 Kumar AmitDirector, Chief Executive Officer Buy 21,000 2.50 $52,500 630,812 Form 4
2026-01-28 Baskies Arnold MDirector Buy 10,000 3.04 $30,400 135,000 Form 4
2025-07-31 Titterton Lewis H jrDirector Buy 10,000 3.08 $30,800 953,334 Form 4
2025-07-30 Kumar AmitChief Executive Officer Buy 5,000 3.16 $15,800 579,925 Form 4
2025-07-18 Baskies Arnold MDirector Buy 5,000 3.39 $16,950 125,000 Form 4
2025-07-11 Titterton Lewis H jrDirector Buy 10,000 3.14 $31,400 943,334 Form 4
2025-07-11 Kumar AmitChief Executive Officer Buy 5,000 3.15 $15,750 574,925 Form 4
2025-06-04 Kumar AmitChief Executive Officer Buy 10,000 2.85 $28,500 569,925 Form 4
2025-01-28 Baskies Arnold MDirector Buy 5,000 2.82 $14,100 120,000 Form 4
2025-01-24 Titterton Lewis H jrDirector Buy 1,000 3.00 $3,000 933,334 Form 4
2025-01-23 Titterton Lewis H jrDirector Buy 2,000 2.91 $5,820 932,334 Form 4
2025-01-22 Titterton Lewis H jrDirector Buy 2,000 3.01 $6,020 930,334 Form 4
2025-01-21 Titterton Lewis H jrDirector Buy 6,000 2.59 $15,540 928,334 Form 4
2025-01-17 Titterton Lewis H jrDirector Buy 10,000 2.57 $25,700 922,334 Form 4
2025-01-15 Catelani MichaelPresident, COO, & CFO Buy 9,289 2.15 $19,971 44,500 Form 4
2025-01-15 Kumar AmitChief Executive Officer Buy 43,000 2.23 $95,890 559,925 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

4 × option exercise2 × shares withheld for tax
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-07-27 Baskies Arnold MDirector Option exercise M +6,000 3.13 141,000 Form 4
2026-07-27 Baskies Arnold MDirector Shares withheld for tax F −5,428 3.46 135,572 Form 4
2025-12-15 Titterton Lewis H jrDirector Option exercise M +16,000 2.92 969,334 Form 4
2025-10-30 Kumar AmitChief Executive Officer Option exercise M +200,000 2.92 779,925 Form 4
2025-10-30 Kumar AmitChief Executive Officer Shares withheld for tax F −169,439 4.06 610,486 Form 4
2024-10-22 Titterton Lewis H jrDirector Option exercise M +16,000 2.58 912,334 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Anixa Biosciences's scores and multiples ›